Stockscreener 앱 받기
11.18
1.27%
0.14
시간 외 거래:
11.14
-0.04
-0.36%
전일 마감가:
$11.04
열려 있는:
$11.15
하루 거래량:
62,609
Relative Volume:
0.59
시가총액:
$293.48M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-1.0208
EPS:
-10.9518
순현금흐름:
$-18.07M
1주 성능:
-15.62%
1개월 성능:
-23.48%
6개월 성능:
+3.81%
1년 성능:
+21.26%
1일 변동 폭
$11.02
$11.99
1주일 범위
$11.02
$13.15
52주 변동 폭
$7.05
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.18 | 347.82M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | TD Cowen | Buy |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
What drives Benitec Biopharma Inc. stock priceAccelerated earnings growth - Autocar Professional
Benitec Biopharma Inc. Stock Analysis and ForecastBreakout portfolio performance - Autocar Professional
Is Benitec Biopharma Inc. a good long term investmentUnrivaled growth potential - jammulinksnews.com
What analysts say about Benitec Biopharma Inc. stockFree Stock Market Mentorship - Autocar Professional
(BNTC) Investment Report - news.stocktradersdaily.com
Does Benitec Biopharma Inc. stock pay reliable dividendsFree Investment Community - Newser
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Buy” by Analysts - Defense World
What analysts say about Benitec Biopharma Inc. stock outlookSmart High Yield Swing Trades - Newser
Why Benitec Biopharma Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - beatles.ru
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trial progress - Investing.com Australia
How Benitec Biopharma Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
What makes Benitec Biopharma Inc. stock price move sharplyTriple Digit Return Forecasts - Newser
Citizens JMP Reaffirms Their Buy Rating on Benitec Biopharma (BNTC) - The Globe and Mail
Benitec BioPharma stock maintains Market Outperform rating at JMP By Investing.com - Investing.com Canada
Benitec completes first cohort in gene therapy trial, advances to next phase By Investing.com - Investing.com South Africa
When the Price of (BNTC) Talks, People Listen - news.stocktradersdaily.com
Benitec Biopharma Advances BB-301 Clinical Study - TipRanks
Benitec Biopharma Provides Operational Updates - GlobeNewswire
Benitec Biopharma Inc. Provides Operational Updates - MarketScreener
Benitec Biopharma (BNTC) Moves Forward with Clinical Study Enrollment | BNTC Stock News - GuruFocus
Benitec completes first cohort in gene therapy trial, advances to next phase - Investing.com
Benitec's BB-301 Gene Therapy Achieves Key Safety Milestone, Phase 1b/2a Trial Set to Expand - Stock Titan
Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at TD Cowen - Defense World
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 3000 Index - MarketScreener
Benitec Biopharma Inc.(NasdaqCM: BNTC) added to Russell 3000 Growth Index - MarketScreener
Benitec Biopharma(BNTC) Plunges 8.10% on Earnings Concerns - AInvest
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Trading (BNTC) With Integrated Risk Controls - news.stocktradersdaily.com
GAMMA Investing LLC Grows Stake in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Nasdaq
(BNTC) Trading Report - news.stocktradersdaily.com
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Position Boosted by Ameriprise Financial Inc. - Defense World
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):